Danaher Corporation (DHR) reported quarterly earnings results on Monday, Jul-25-2016. The company said it had a profit of $1.25 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $1.22. The company posted revenue of $5785.00 million in the period, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation opened for trading at $81.28 and hit $81.6 on the upside on Wednesday, eventually ending the session at $81.39, with a gain of 0.63% or 0.51 points. The heightened volatility saw the trading volume jump to 23,29,981 shares. Company has a market cap of $56,053 M.
In a different news, on Jul 19, 2016, John T Schwieters (director) sold 2,500 shares at $97.05 per share price. According to the SEC, on May 13, 2016, Angela S Lalor (SVP, Human Resources) sold 8,392 shares at $97.77 per share price. On Apr 29, 2016, James A Lico (Executive Vice President) sold 58,954 shares at $96.86 per share price, according to the Form-4 filing with the securities and exchange commission.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.